News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alnara Pharmaceuticals, Inc. Announces Promotion of Robert Gallotto to Chief Business Officer


4/16/2009 8:51:44 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnara Pharmaceuticals, Inc., a pharmaceutical company developing novel, non-systemic orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today the promotion of Robert Gallotto to chief business officer. This appointment reflects Alnara’s growing operations as the company prepares to submit a new drug application (NDA) and commercialize liprotamase, a novel, oral, porcine-free pancreatic enzyme replacement therapy (PERT) that has already completed a Phase 3 efficacy trial.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES